866-997-4948(US-Canada Toll Free)

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026

Published By :

GlobalData

Published Date : Sep 2017

Category :

Pharmaceutical

No. of Pages : 50 Pages

EpiCast Report: Osteoarthritis - Epidemiology Forecast to 2026

Summary

Osteoarthritis (OA) is a gradually progressive joint disease that is typically seen in middle-aged to elderly people. According to the American College of Rheumatology (ACR), OA is the most common cause of disability in the elderly. The most commonly affected joints are the knee, hip, hand, and spine. It is characterized by breakdown of the cartilage, bony changes of the joints, deterioration of tendons and ligaments, and various degrees of inflammation of the joint lining.

To forecast the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA in the 7MM, GlobalData epidemiologists selected nationally representative, population-based studies that provided these epidemiological data in the 7MM. GlobalData epidemiologists obtained data for the diagnosed prevalent cases (symptomatic) as well as data for the severity segmentation of the diagnosed prevalent cases (symptomatic) from primary market research. In addition, the forecast is supported by robust, country-specific data that was obtained from various authentic sources such as research articles published in peer-reviewed journals.

In the 7MM, GlobalData epidemiologists forecast that the diagnosed prevalent cases (symptomatic) of hand OA will increase from 17,948,101 cases in 2016 to 20,413,591 cases in 2026 at an annual growth rate (AGR) of 1.37%, the diagnosed prevalent cases (symptomatic) of knee OA will increase from 15,235,201 cases in 2016 to 17,641,626 cases in 2026 at an AGR of 1.58%, and the diagnosed prevalent cases (symptomatic) of hip OA will increase from 3,361,141 cases in 2016 to 3,867,480 cases in 2026 at an AGR of 1.51%.

Scope

- The Osteoarthritis (OA) EpiCast Report provides an overview of the risk factors and global trends of hand OA, knee OA, and hip OA in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- It includes a 10-year epidemiological forecast for the total prevalent cases (radiographic), total prevalent cases (symptomatic), and diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA segmented by age (beginning at 18 years and older) and sex in these markets. The diagnosed prevalent cases (symptomatic) of hand OA, knee OA, and hip OA are further segmented by severity using Kellgren-Lawrence (KL) grading into mild (KL = 2), and moderate to severe (KL = 3 to 4).
- The OA epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The OA EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global OA market.
- Quantify patient populations in the global OA market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for OA therapeutics in each of the markets covered.
- Understand magnitude of OA population by disease severity.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Osteoarthritis: Executive Summary 5
2.1 Related Reports 8
2.2 Upcoming Reports 8
3 Epidemiology 9
3.1 Disease Background 9
3.2 Risk Factors and Comorbidities 10
3.3 Global and Historical Trends 11
3.4 Forecast Methodology 14
3.4.1 Sources 15
3.4.2 Forecast Assumptions and Methods 20
3.5 Epidemiological Forecast for OA (2016-2026) 26
3.5.1 Total Prevalent Cases (Radiographic) of Hand OA 26
3.5.2 Total Prevalent Cases (Symptomatic) of Hand OA 26
3.5.3 Diagnosed Prevalent Cases (Symptomatic) of Hand OA 27
3.5.4 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA 28
3.5.5 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA 28
3.5.6 Diagnosed Prevalent Cases (Symptomatic) of Hand OA by Severity 29
3.5.7 Total Prevalent Cases (Radiographic) of Knee OA 30
3.5.8 Total Prevalent Cases (Symptomatic) of Knee OA 31
3.5.9 Diagnosed Prevalent Cases (Symptomatic) of Knee OA 32
3.5.10 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA 33
3.5.11 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA 34
3.5.12 Diagnosed Prevalent Cases (Symptomatic) of Knee OA by Severity 35
3.5.13 Total Prevalent Cases (Radiographic) of Hip OA 36
3.5.14 Total Prevalent Cases (Symptomatic) of Hip OA 37
3.5.15 Diagnosed Prevalent Cases (Symptomatic) of Hip OA 38
3.5.16 Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA 39
3.5.17 Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA 40
3.5.18 Diagnosed Prevalent Cases (Symptomatic) of Hip OA by Severity 41
3.6 Discussion 42
3.6.1 Epidemiological Forecast Insight 42
3.6.2 Limitations of Analysis 42
3.6.3 Strengths of Analysis 43
4 Appendix 44
4.1 Bibliography 44
4.2 High-Prescribing Physician Survey 47
4.3 About the Authors 48
4.3.1 Epidemiologist 48
4.3.2 Reviewers 48
4.3.3 Global Director of Therapy Analysis and Epidemiology 49
4.3.4 Global Head and EVP of Healthcare Operations and Strategy 49
4.4 About GlobalData 50
4.5 Contact Us 50
4.6 Disclaimer 50

1.1 List of Tables
Table 1: Risk Factors and Comorbidities for OA 11
Table 2: Severity Scoring System for Classifying the Hand, Knee, and Hip OA Using the KL Grading Scale. 15
Table 3: 7MM, Total Prevalent Cases (Radiographic) of Hand OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 26
Table 4: 7MM, Total Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 27
Table 5: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 27
Table 6: 7MM, Total Prevalent Cases (Radiographic) of Knee OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 31
Table 7: 7MM, Total Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 31
Table 8: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 32
Table 9: 7MM, Total Prevalent Cases (Radiographic) of Hip OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 36
Table 10: 7MM, Total Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 37
Table 11: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages 18 Years, N, Selected Years 2016-2026 38
Table 12: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2017 47

1.2 List of Figures
Figure 1: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages 18 Years, 2016 and 2026 6
Figure 2: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages 18 Years, 2016 and 2026 7
Figure 3: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages 18 Years, 2016 and 2026 8
Figure 4: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Hand OA, Men and Women, Ages 18 Years, 2016 12
Figure 5: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Knee OA, Men and Women, Ages 18 Years, 2016 13
Figure 6: 7MM, Age-Standardized Diagnosed Prevalence (Symptomatic) (%), Hip OA, Men and Women, Ages 18 Years, 2016 14
Figure 7: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Hand OA 15
Figure 8: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Hand OA 16
Figure 9: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Knee OA 17
Figure 10: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Knee OA 18
Figure 11: 7MM, Sources Used to Forecast Total Prevalent Cases (Radiographic), Hip OA 19
Figure 12: 7MM, Sources Used to Forecast Total Prevalent Cases (Symptomatic), Hip OA 20
Figure 13: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages 18 Years, N, 2016 28
Figure 14: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hand OA, Both Sexes, Ages 18 Years, N, 2016 29
Figure 15: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hand OA by Severity, Both Sexes, Ages 18 Years, N, 2016 30
Figure 16: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages 18 Years, N, 2016 33
Figure 17: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Knee OA, Both Sexes, Ages 18 Years, N, 2016 34
Figure 18: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Knee OA by Severity, Both Sexes, Ages 18 Years, N, 2016 35
Figure 19: 7MM, Age-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages 18 Years, N, 2016 39
Figure 20: 7MM, Sex-Specific Diagnosed Prevalent Cases (Symptomatic) of Hip OA, Both Sexes, Ages 18 Years, N, 2016 40
Figure 21: 7MM, Diagnosed Prevalent Cases (Symptomatic) of Hip OA by Severity, Both Sexes, Ages 18 Years, N, 2016 41

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *